stockrowAlkermes plc (ALKS) vs Indivior Pharmaceuticals Inc. (SUPN)
- Alkermes plc ALKS 44.61 −2.79%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
Alkermes plc and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $7.5B against $5.6B — 1.3× the size. Alkermes plc has negative trailing earnings, so its P/E is not meaningful; Indivior Pharmaceuticals Inc. trades at 7.6×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 16.4% against 15.3%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs −0.02%) and the higher return on invested capital (283.0% vs 1.54%). Across the 19 metrics below, Indivior Pharmaceuticals Inc. leads on 13 and Alkermes plc on 6.
Valuation
Profitability
| Metric | ALKS | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.89% | 84.85% | 53.51% |
| Operating margin | 3.66% | 40.57% | 0.00% |
| Net margin | (0.02%) | 32.85% | (2.45%) |
| Free cash flow margin | 13.03% | 2.26% | 0.00% |
| Return on equity | (0.02%) | (337.83%) | (0.80%) |
| Return on assets | (0.01%) | 32.82% | (1.67%) |
| Return on invested capital | 1.54% | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack